Compounders Research Compare

Phio Pharmaceuticals Corp.(PHIO)

Biotechnology · King of Prussia, PA

$0.99+0.00 (+0.34%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.

King of Prussia, PA

6 employees

www.phiopharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Robert L. Bitterman

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T21:23:02.648Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:23:02.648Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -1.34
Quote price: 0.9944

FMP input reference: ca628ff6f55b6345e2cefca22780bd34dfabddebf8a5c62bf0c86d2d29f40561

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

PHIO Earnings Yield Metrics

EARNINGS YIELD

N/A

PHIO Competitors' Earnings Yield

Phio Pharmaceuticals Corp.

Current

Market Cap

$11.55M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Caring Brands, Inc.

Market Cap

$11.36M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IRIDEX Corporation

Market Cap

$11.77M

Earnings Yield

N/A

TTM Avg

3.64%

3Y Avg

4.51%

5Y Avg

4.95%

Biofrontera Inc.

Market Cap

$11.93M

Earnings Yield

N/A

TTM Avg

10.43%

3Y Avg

10.43%

5Y Avg

10.43%

VistaGen Therapeutics, Inc.

Market Cap

$11.12M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Kiora Pharmaceuticals, Inc.

Market Cap

$11.08M

Earnings Yield

N/A

TTM Avg

44.71%

3Y Avg

44.71%

5Y Avg

44.71%

Cellectar Biosciences, Inc.

Market Cap

$12.06M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Lisata Therapeutics, Inc.

Market Cap

$11.02M

Earnings Yield

N/A

TTM Avg

53.42%

3Y Avg

53.42%

5Y Avg

53.42%

CytoMed Therapeutics Limited

Market Cap

$11.00M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cerenome, Inc.

Market Cap

$10.94M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Phio Pharmaceuticals Corp. (PHIO)	$11.55M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$11.36M	N/A	N/A	N/A	N/A
IRIDEX Corporation (IRIX)vs ›	$11.77M	N/A	3.64%	4.51%	4.95%
Biofrontera Inc. (BFRI)vs ›	$11.93M	N/A	10.43%	10.43%	10.43%
VistaGen Therapeutics, Inc. (VTGN)vs ›	$11.12M	N/A	N/A	N/A	N/A
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.08M	N/A	44.71%	44.71%	44.71%
Cellectar Biosciences, Inc. (CLRB)vs ›	$12.06M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$11.02M	N/A	53.42%	53.42%	53.42%
CytoMed Therapeutics Limited (GDTC)vs ›	$11.00M	N/A	N/A	N/A	N/A
Cerenome, Inc. (CNSY)vs ›	$10.94M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics